These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


128 related items for PubMed ID: 8655347

  • 1. [Benzamil and mucoviscidosis. Primary culture of nasal mucosa as an electrophysiologic in vitro model].
    Blank U, Glanz H, Eistert B, Fryen A, Lindemann H, Hüls G, Clauss W, Weber WM.
    HNO; 1996 Apr; 44(4):172-7. PubMed ID: 8655347
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
    Hirsh AJ, Sabater JR, Zamurs A, Smith RT, Paradiso AM, Hopkins S, Abraham WM, Boucher RC.
    J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
    [Abstract] [Full Text] [Related]

  • 3. [Pharmacology of ion channels in mucoviscidosis. Physiological bases and therapeutic applications].
    Danner I, Baro-Puigdemasa I, Escande D.
    Rev Pneumol Clin; 1995 Dec; 51(3):186-92. PubMed ID: 7569582
    [Abstract] [Full Text] [Related]

  • 4. The amiloride-inhibitable Na+ conductance is reduced by the cystic fibrosis transmembrane conductance regulator in normal but not in cystic fibrosis airways.
    Mall M, Bleich M, Greger R, Schreiber R, Kunzelmann K.
    J Clin Invest; 1998 Jul 01; 102(1):15-21. PubMed ID: 9649552
    [Abstract] [Full Text] [Related]

  • 5. N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.
    Rochat T, Lacroix JS, Jornot L.
    J Cell Physiol; 2004 Oct 01; 201(1):106-16. PubMed ID: 15281093
    [Abstract] [Full Text] [Related]

  • 6. Parallel improvement of sodium and chloride transport defects by miglustat (n-butyldeoxynojyrimicin) in cystic fibrosis epithelial cells.
    Noël S, Wilke M, Bot AG, De Jonge HR, Becq F.
    J Pharmacol Exp Ther; 2008 Jun 01; 325(3):1016-23. PubMed ID: 18309088
    [Abstract] [Full Text] [Related]

  • 7. Effects of topically delivered benzamil and amiloride on nasal potential difference in cystic fibrosis.
    Hofmann T, Stutts MJ, Ziersch A, Rückes C, Weber WM, Knowles MR, Lindemann H, Boucher RC.
    Am J Respir Crit Care Med; 1998 Jun 01; 157(6 Pt 1):1844-9. PubMed ID: 9620916
    [Abstract] [Full Text] [Related]

  • 8. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I, Roussel D, Bui S, Deneuville E, Huet F, Reix P, Bellon G, Lenoir G, Edelman A.
    BMC Pediatr; 2006 Oct 03; 6():25. PubMed ID: 17018149
    [Abstract] [Full Text] [Related]

  • 9. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
    Mall MA.
    Exp Physiol; 2009 Feb 03; 94(2):171-4. PubMed ID: 19060118
    [Abstract] [Full Text] [Related]

  • 10. Minor role of Cl- secretion in non-cystic fibrosis and cystic fibrosis human nasal epithelium.
    Rückes-Nilges C, Weber U, Lindemann H, Münker G, Clauss W, Weber WM.
    Cell Physiol Biochem; 1999 Feb 03; 9(1):1-10. PubMed ID: 10352340
    [Abstract] [Full Text] [Related]

  • 11. Expression of CFTR from a ciliated cell-specific promoter is ineffective at correcting nasal potential difference in CF mice.
    Ostrowski LE, Yin W, Diggs PS, Rogers TD, O'Neal WK, Grubb BR.
    Gene Ther; 2007 Oct 03; 14(20):1492-501. PubMed ID: 17637798
    [Abstract] [Full Text] [Related]

  • 12. Amiloride-insensitive nasal potential difference varies with the menstrual cycle in cystic fibrosis.
    Sweezey NB, Smith D, Corey M, Ellis L, Carpenter S, Tullis DE, Durie P, O'Brodovich HM.
    Pediatr Pulmonol; 2007 Jun 03; 42(6):519-24. PubMed ID: 17469152
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The effect of varying tonicity on nasal epithelial ion transport in cystic fibrosis.
    Davies MG, Geddes DM, Alton EW.
    Am J Respir Crit Care Med; 2005 Apr 01; 171(7):760-3. PubMed ID: 15618459
    [Abstract] [Full Text] [Related]

  • 16. Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.
    Stanton BA.
    Wien Klin Wochenschr; 1997 Jun 27; 109(12-13):457-64. PubMed ID: 9261986
    [Abstract] [Full Text] [Related]

  • 17. Measurement of airway ion transport assists the diagnosis of cystic fibrosis.
    Middleton PG, House HH.
    Pediatr Pulmonol; 2010 Aug 27; 45(8):789-95. PubMed ID: 20597077
    [Abstract] [Full Text] [Related]

  • 18. [Amiloride inhalation therapy in mucoviscidosis].
    Lindemann H.
    Monatsschr Kinderheilkd; 1993 May 27; 141(5):392-4. PubMed ID: 8326957
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
    Zabner J, Cheng SH, Meeker D, Launspach J, Balfour R, Perricone MA, Morris JE, Marshall J, Fasbender A, Smith AE, Welsh MJ.
    J Clin Invest; 1997 Sep 15; 100(6):1529-37. PubMed ID: 9294121
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.